ARCHIVES

Biotherapeutics Reports LAK/IL-2 Toxicity Reduced With Constant Infusion Of IL-2

This article is from The Cancer Letter archive.

Vol. 13 No. 16 | April 17, 1987

Download PDF Visit The Full Archive

Related Articles

FDA Selects 23 Survivors To Review Drug Applications.

June 15, 2001

In Brief: ONS Invites Proposals For Research On Hazards Of Chemotherapy; UTSCC Adopts Code Of Ethics

August 31, 1984

House Approves $619M Increase For NIH.

February 2, 2007

Advisors seek support for NCI’s “special authorities” granted in 1971.

July 15, 2005

Kimes Calls Headline On DRG ‘Exaggerated Negativity’ In Letter

April 5, 1991

CTRC Wins Renewal Of Cancer Center Grant; New Mexico To Lead Systems Biology Center

September 4, 2009